Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide | Zendy

Hashimoto Akiko | Zendy; Tanaka Yasuhiro | Zendy; Ishikawa Takayuki | Zendy; Shinzato Isaku | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Successful treatment of acute promyelocytic leukemia in a patient under hemodialysis with arsenic trioxide

Author(s) -

Hashimoto Akiko,

Tanaka Yasuhiro,

Ishikawa Takayuki,

Shinzato Isaku

Publication year - 2021

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.4417

Subject(s) - arsenic trioxide , acute promyelocytic leukemia , medicine , hemodialysis , kidney disease , adverse effect , arsenic , intensive care medicine , retinoic acid , biochemistry , materials science , chemistry , metallurgy , gene

A man with chronic kidney disease (CKD) under hemodialysis was diagnosed with acute promyelocytic leukemia (APL). He received arsenic trioxide as a single agent and achieved complete molecular remission without severe adverse events. Arsenic trioxide (ATO) can be used safely and effectively for APL with CKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research